The Claim
In L6 rat skeletal muscle cells under insulin stimulation, knockdown of KLF3 increases phosphorylation of TBC1D1 at Thr590 and TBC1D4 at Thr642 by 30–40% without altering total protein levels, indicating that KLF3 modulates insulin signaling downstream of AKT through regulation of TBC1D1 and TBC1D4.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In rat muscle cells exposed to insulin, reducing the amount of KLF3 protein increases the phosphorylation of TBC1D1 and TBC1D4 at specific sites by 30–40%, without changing the total amount of these proteins.
See the scientific wording
In L6 rat skeletal muscle cells, KLF3 knockdown increases phosphorylation of TBC1D1 at Thr590 and TBC1D4 at Thr642 by 30–40% under insulin stimulation, without altering total protein levels, indicating KLF3 modulates insulin signaling downstream of AKT by regulating these key Rab-GTPase regulators.
When KLF3 levels drop in muscle cells, the cell produces more of the proteins that help insulin signal properly and fewer of the proteins that block insulin. This causes insulin to activate AKT more strongly, which then adds phosphate groups to TBC1D1 and TBC1D4. These phosphorylated proteins stop blocking GLUT4 transporters from moving to the cell surface, so more glucose enters the cell.
What the research says
1 studyStudy: KLF3 impacts insulin sensitivity and glucose uptake in skeletal muscle.
Turning down the KLF3 gene in rat muscle cells makes insulin work better to move sugar into the cells by activating two key proteins (TBC1D1 and TBC1D4) without changing how much of those proteins are there.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.